SELLAS Life Sciences Group, Inc. Convertible Notes Payable, Noncurrent
SELLAS Life Sciences Group, Inc. (SLS) had Convertible Notes Payable, Noncurrent of $1.00 million as of 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2012-05-14
- 2012-03-31: Convertible Notes Payable, Noncurrent $1.00M.
- 2011-12-31: Convertible Notes Payable, Noncurrent $0.00.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2012-03-31 | $1.00M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $0.00 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |